What are carbonic anhydrase inhibitors?
Carbonic anhydrants inhibitors are pharmaceutical substances that suppress the effect of carbonic anhydrase - an enzyme that plays a major role in the regulation of pH and fluid levels in the human body. These drugs are often used to control glaucoma, epilepsy and mountain illness. They can also be used as diuretics, in the treatment of certain types of stomach ulcers, some neurological disorders and osteoporosis. It is largely responsible for the conversion of carbon dioxide into carbonate and hydrogen -bodied ions. Some tasks associated with this action are regulation of acid levels in the stomach and water content in the kidneys and eye cells, as well as other body tissues. It also helps to remove excess carbon dioxide from the body and ensure the proper functioning of the pancreas.
When carbonical anhyinhibitors of the buddy are used, they usually work by reducing the absorption of bicarbonate ions of the body. They also reduce salt absorption. This results in a reduction in fluid levels in the body and therefore their use as a diuretic agent.
Anti-glaukoma pharmaceuticals, which are carbonic anhydrains inhibitors, include, among other things, acetazolamide, dichlorphrenomide and methazolamide. These drugs usually work by reducing the amount of fluid - known as water humor, which is usually regulated by bicarbonate ions - which the eye produces. The most common method of administration of these drugs is eye drops. This relieves the pressure on the eye caused by glaucoma and helps to maintain vision.
risks associated with prolonged use of carbonic anhydrase inhibitors include renal failure and liver disease. These drugs also tend to increase blood and urine sugar in diabetics. Others, these drugs can increase shortness of breath in patients suffering from emphysema.
Some of the most common side effects that patients may experience when taking carbonic anhydrase inhibitors are fatigue, weakness, diarrhea, nausea and numbness at the ends. Some less common side effectsThey include blood or problems with urination, back and depression. More rare side effects are, among other things, hives, convulsions and unusual bruises or bleeding.
Medical research of carbonic anhydrase inhibitors suggests that they can play a role in preventing renal cells from preventing some kind of kidney cancer. It seems to be the result of the ability of these pharmaceuticals to affect pH levels. It is possible that it would be a good complementary treatment of other types of chemotherapy used to treat kidney cancer.